四川路橋(600039.SH):擬收購川鐵建公司、航焱公司、臻景公司51%及以上股權
格隆匯 2 月 23日丨四川路橋(600039.SH)公佈,為進一步拓展公司施工業務範圍,增強公司核心競爭力,公司或公司控制的子公司擬收購關聯方所持川鐵建公司、航焱公司、臻景公司51%及以上股權,控股該三家公司。
此次收購目的是為提升公司在鐵路、市政、房建領域的競爭能力,進一步開拓川南片區市場,公司或公司控制的子公司擬收購川鐵建公司、航焱公司、臻景公司51%及以上股權,控股該三家公司,具體收購方案待審計及評估工作完成後確定。
此次交易有利於進一步拓展公司施工業務範圍,將提升公司在鐵路、市政、房建領域的競爭能力,同時有利於公司進一步開拓川南片區市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.